期刊文献+

口腔鳞状细胞癌组织中FHIT蛋白表达变化及意义 被引量:1

暂未订购
导出
摘要 目的观察口腔鳞状细胞癌(OSCC)组织中脆性组氨酸三聚体(FHIT)蛋白表达变化,并探讨其临床意义。方法采用免疫组化法检测36例OSCC组织(癌症组)及41例正常口腔黏膜组织(对照组)中的FHIT蛋白,分析其与OSCC患者临床病理参数的关系。结果癌症组FHIT蛋白表达阳性率为30.56%(11/36)、对照组为78.05%(32/41),P<0.05。FHIT蛋白表达与OSCC患者的年龄、性别、淋巴结转移无关(P均>0.05),而与肿瘤分化程度、病理分期有关(P均<0.05)。结论 OSCC组织中FHIT蛋白表达降低,FHIT蛋白在OSCC发生、发展过程中发挥一定的作用。
出处 《山东医药》 CAS 北大核心 2016年第2期68-69,共2页 Shandong Medical Journal
基金 吉林省科技厅发展计划项目(201105037)
  • 相关文献

参考文献15

  • 1Cheng Z, Hu L, Fu W, et al variants in gastric cancer[ J]. Sci, 2007,27 (4) :393-398.
  • 2Wang tiT, Qian XP, Liu BR. Expression of survivin and its splice J Huazhong Univ Sci Technolog Med Survivin : potential role in diagnosis,prognosisand targeted therapy of gastric cancer[ J]. World J Gas- troenterol, 2007,13 (20) :2784-2790.
  • 3魏良洲,陈东育,宋兆峰.Survivin基因在胃癌组织中的表达及临床意义[J].山东医药,2005,45(16):37-38. 被引量:3
  • 4谷建琦,张英怀,杨威,张杰英,蒋崇槟,贾志宇.脆性组氨酸三聚体基因及错配修复基因hMLH_1在口腔鳞状细胞癌中的表达及意义[J].第三军医大学学报,2007,29(2):151-153. 被引量:7
  • 5Pekarsky Y, Zanesi N, Palamarchuk A, et al. FHIT: fromgenedis- covery to cancer treatment and prevention [ J ]. l_ancet Oncol, 2002,3 (12) :748-754.
  • 6Shin S, Sung B J, Cho YS, et al. An anti apoptotic protein human Surivinis a direct inhibitor of Caspase 3 and 7 [ J ]. Biochemistry, 2001,40(4) :1117-1123.
  • 7Noguehi T, Takeno S, Kimura Y, et al. FHIT expression andhy- permethylation in esophageal squamous cell carcinoma [ J ]. Int J Mol Med, 2003,11(4): 441-447.
  • 8Dong .IT, Li CL Sipe TW, et al. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients [ J ]. Clin Cancer Res, 2001,7(2) :304-308.
  • 9Backman SA, Ghazarian D, So K, et al. Early onsetofneoplasiain the prostate and skin ofmice with tissue-specific deletion'of pten [J]. Proc Natl Aead Sci USA, 2004,101 (6) :1725-1730.
  • 10Guo Z, Johansson SL, Rhim JS, et al. Fragile histidine triad gene- expression in prmi ary prostate eancerand in anin vitromodd [ J ]. Prostate, 2000,43(2) :101-110.

二级参考文献43

  • 1夏雪雁,李连宏,李先承,姜涛.凋亡抑制基因Survivin和抑癌基因PTEN在前列腺癌组织中的表达及临床意义[J].中华男科学杂志,2006,12(4):346-348. 被引量:17
  • 2[21]Klaes R, Benner A, Friedrich T et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol, 2002, 26:1389
  • 3[22]von Knebel, Doeberitz M. New molecular tools for efficient screening of cervical cancer. Dis Markers, 2001,17:123
  • 4[23]Sano T, Oyama T, Kashiwabara K et al. lmmunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intreapithelial neoplasia. Pathol Int,1998,48:580
  • 5[14]Thiagalingam S, Lisitsyn NA, Hamaguchi M, et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res, 1996,56:2936
  • 6[15]Hao XP, Willis JE, Pretlow TG et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res, 2000, 60:18
  • 7[16]Yuan BZ,Keck-Waggoner C, Zimonjic DB et al. Alterations of the FHIT gene in human prostatic carcinoma. Cancer Res, 2000, 60:1049
  • 8[17]Chaudhuri AR, Khan IA, Prasad V et al. The tumor suppressor protein Fhit. A novel interaction with tubulin. J Biol Chem, 1999, 274:24378
  • 9[18]Guo Z, Johansson SL, Rhim JS et al. Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model. Prostate,2000,43:101
  • 10[19]Henshall SM , Quinn DI, Lee CS et al Overexpression of the cell cycle inhibitor p16 INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients. Clin Cancer Res,2001,7:544

共引文献18

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部